Apraclonidine Ophthalmic (Akorn Inc.)
Welcome to the PulseAid listing for the Apraclonidine Ophthalmic drug offered from Akorn Inc.. This Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Akorn Inc. |
NON-PROPRIETARY NAME: | Apraclonidine Hydrochloride |
SUBSTANCE NAME: | APRACLONIDINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |
ROUTE: | OPHTHALMIC |
DOSAGE FORM: | SOLUTION/ DROPS |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2009-08-12 |
END MARKETING DATE: | 0000-00-00 |
Apraclonidine Ophthalmic HUMAN PRESCRIPTION DRUG Details:
Item Description | Apraclonidine Ophthalmic from Akorn Inc. |
LABELER NAME: | Akorn Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/mL) |
START MARKETING DATE: | 2009-08-12 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 17478-716_755eee9a-5377-40af-b98e-51a1ce669c9e |
PRODUCT NDC: | 17478-716 |
APPLICATION NUMBER: | ANDA077764 |
Other APRACLONIDINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: